A detailed history of Deutsche Bank Ag\ transactions in Procept Bio Robotics Corp stock. As of the latest transaction made, Deutsche Bank Ag\ holds 93,953 shares of PRCT stock, worth $6.22 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
93,953
Previous 20,217 364.72%
Holding current value
$6.22 Million
Previous $1.24 Million 509.39%
% of portfolio
0.0%
Previous 0.0%

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

BUY
$56.31 - $84.99 $4.15 Million - $6.27 Million
73,736 Added 364.72%
93,953 $7.53 Million
Q2 2024

Aug 14, 2024

SELL
$45.73 - $69.19 $99,599 - $150,695
-2,178 Reduced 9.73%
20,217 $1.24 Million
Q1 2024

May 15, 2024

BUY
$40.38 - $50.75 $120,009 - $150,829
2,972 Added 15.3%
22,395 $1.11 Million
Q4 2023

Feb 14, 2024

BUY
$24.89 - $43.41 $40,346 - $70,367
1,621 Added 9.11%
19,423 $814,000
Q3 2023

Nov 09, 2023

BUY
$30.02 - $38.81 $62,081 - $80,259
2,068 Added 13.14%
17,802 $584,000
Q2 2023

Aug 14, 2023

SELL
$26.7 - $37.02 $36,018 - $49,939
-1,349 Reduced 7.9%
15,734 $556,000
Q1 2023

May 15, 2023

SELL
$26.64 - $39.74 $1.99 Million - $2.97 Million
-74,752 Reduced 81.4%
17,083 $485,000
Q4 2022

Feb 13, 2023

SELL
$38.78 - $46.78 $96,368 - $116,248
-2,485 Reduced 2.63%
91,835 $3.81 Million
Q3 2022

Nov 14, 2022

BUY
$30.9 - $50.65 $2.52 Million - $4.12 Million
81,435 Added 632.01%
94,320 $3.91 Million
Q2 2022

Aug 11, 2022

BUY
$29.23 - $44.45 $252,050 - $383,292
8,623 Added 202.32%
12,885 $421,000
Q1 2022

May 13, 2022

SELL
$16.89 - $35.74 $2,212 - $4,681
-131 Reduced 2.98%
4,262 $149,000
Q4 2021

Feb 11, 2022

BUY
$24.6 - $46.29 $108,067 - $203,351
4,393 New
4,393 $110,000

Others Institutions Holding PRCT

About PROCEPT BioRobotics Corp


  • Ticker PRCT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 44,592,300
  • Market Cap $2.95B
  • Description
  • PROCEPT BioRobotics Corporation, a surgical robotics company, develops transformative solutions in urology. It develops, manufactures, and sells AquaBeam Robotic System, an image-guided, surgical robotic system for use in minimally-invasive urologic surgery with a focus on treating benign prostatic hyperplasia (BPH). The company also designs Aqu...
More about PRCT
Track This Portfolio

Track Deutsche Bank Ag\ Portfolio

Follow Deutsche Bank Ag\ and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Deutsche Bank Ag\, based on Form 13F filings with the SEC.

News

Stay updated on Deutsche Bank Ag\ with notifications on news.